Alliance for Clinical Trials in Oncology: Small Cell Lung Carcinoma trials

The registry lists 16 Small Cell Lung Carcinoma studies with Alliance for Clinical Trials in Oncology as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 1Phase 2 13Phase 3 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family CaregiversCompletedNCT02349412Phase 3Results posted
• Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung CancerTerminatedNCT01017601Phase 2Results posted
• Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00227565Phase 2
• Liposomal SN-38 in Treating Patients With Small Cell Lung CancerWithdrawnNCT00104754Phase 2
• Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00072527Phase 2
• Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00041054Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00033696Phase 2
• Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00028925Phase 2
• Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung CancerCompletedNCT00006349Phase 3
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006012Phase 1/2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00005972Phase 2
• Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00005646Phase 2
• Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNCT00004055Phase 2
• Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00003812Phase 2
• Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung CancerCompletedNCT00003299Phase 3
• Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung CancerCompletedNCT00003281Phase 2